National adaptation and implementation. When possible, use:

• fixed-dose combinations rather than co-blistered or loose, single-agent

formulations; and

• for young children and infants, paediatric formulations, with a preference

for solid formulations (e.g. dispersible tablets) rather than liquid formulations.